In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides
about
Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activitySolid-Phase Supports for Oligonucleotide SynthesisSynthesis and monitored selection of 5'-nucleobase-capped oligodeoxyribonucleotides.3'-Exonuclease resistance of DNA oligodeoxynucleotides containing O6-[4-oxo-4-(3-pyridyl)butyl]guanine.Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotidesTriplex technology in studies of DNA damage, DNA repair, and mutagenesisTriplex-forming molecules: from concepts to applications.Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine.Triplex formation with alpha anomers of purine-rich and pyrimidine-rich oligodeoxynucleotidesA role for WRN in telomere-based DNA damage responses.High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells.DNA and RNA derivatives to optimize distribution and deliveryEtoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.DNA triple helices: biological consequences and therapeutic potential.Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.Radiolabeled oligonucleotides for antisense imaging.Oligonucleotide-directed gene-editing technology: mechanisms and future prospects.Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.Characterization of aberrant melting peaks in unlabeled probe assaysInhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro.Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine.Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides.Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination.Biodistribution of antisense nanoparticles in mammary carcinoma rat model.Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3'hydroxypropylamine oligonucleotide.Facile preparation of nuclease resistant 3' modified oligodeoxynucleotides.Oligonucleotide labeling methods. 3. Direct labeling of oligonucleotides employing a novel, non-nucleosidic, 2-aminobutyl-1,3-propanediol backbone.Triplex-forming oligonucleotide target sequences in the human genome.Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study.An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).Aminopyridinyl-Pseudodeoxycytidine Derivatives Selectively Stabilize Antiparallel Triplex DNA with Multiple CG Inversion Sites.
P2860
Q28378628-3D79196E-0C68-4AE4-A959-F62529A53951Q29999315-C73FFBBC-9475-426C-8AA9-BD521CBCAA05Q30953690-A0E86C43-7485-46FB-B983-FB68194A0BB3Q31136142-D8CC25AD-FB3C-474C-997B-0C0661A66743Q33584005-5EC0C4B5-700C-4227-9BC8-C6C9F1094B7EQ33754501-A72A16D6-F80D-4820-8C78-0E1B7C1C7C20Q34179182-5175921C-C0EC-4C22-9F9E-BC1A10AA1881Q34351021-529E05D9-E430-4FA3-BB17-35BD5B63C360Q34590589-881BA667-F016-43FD-AE66-1991624DBD18Q34775902-E7D2EC81-01B2-4101-8BE8-4DEF961FF288Q35062281-10CA58CA-2AF5-42A1-9126-D03DAE828D4CQ35193005-8E121295-3FD3-45DC-9A84-CA0809CADE5CQ35858691-D0EE9AF7-D7FF-4077-87DE-0AA0DC63461FQ36973276-85E9A8F5-E80A-48A1-963D-4A8CA22A5C2BQ36982332-A83C9701-74DA-4E03-B144-65C053CF0BDAQ37732429-2361A8C9-2834-48B0-A8CF-FD05AA3EECBAQ37913042-2AF35F7F-D2BA-4A60-AF0B-E74AF8DBF0E8Q37982821-332AA14C-7565-4629-B4E0-B05F869B255EQ38297805-63CEE3A4-AA13-4D77-932B-8CB5EDEDD501Q38300546-431F9730-6D09-4F36-AE37-02031EC669FDQ38310862-FDD99719-6686-446A-AA8A-B01474C4E3B7Q38348973-52A92F0F-8ED6-4B02-BDF2-390C35D88BCDQ38361012-55D535AD-EAA4-42DC-A328-243773192D8AQ39516277-1D870CC3-2730-453F-B8C0-32A9D2E50D9CQ39709283-FE8C9020-2D63-42B4-84E6-77D9D99572DEQ40398950-50927853-13C6-4678-8F32-1EEC3A0B2535Q40404618-BEF458CE-E40E-4336-A4AE-3A095941215AQ40535854-53D7BE4F-6DBD-48B6-A0F6-D6E073AF60FAQ40695252-170C9707-5E2E-4768-AD69-2AE709807FE7Q42789464-8EC15308-4769-4D0F-8F0C-1754F6E81451Q46197118-C5EF9DB0-A2DD-4B12-AAB1-5D94C0715103Q48088683-91E09026-35BE-4DD0-AADC-3E0DA8E4BC16
P2860
In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@ast
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@en
type
label
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@ast
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@en
prefLabel
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@ast
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@en
P2093
P2860
P356
P1476
In vivo stability and kinetics ...... opropyl amine oligonucleotides
@en
P2093
Kessler DJ
Tinsley JH
Vasquez KM
Zendegui JG
P2860
P304
P356
10.1093/NAR/20.2.307
P407
P577
1992-01-01T00:00:00Z